A rare truncating variant in CHEK2 (1100delC), a G2 checkpoint-kinase, that is involved in cell cycle control and DNA-repair, was identified as a risk factor for breast cancer in two independent studies using this approach [6-8]. Here, CHEK2 is linked to breast carcinoma.